Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in a Murine Model
Marcela Aparicio-Vergara(University Medical Center Groningen), Marten H. Hofker(Maastricht University), Bart van de Sluis(University of Groningen), Nanda Gruben(University Medical Center Groningen), Debby P.Y. Koonen(University Medical Center Groningen), Niels Kloosterhuis(University Medical Center Groningen), Marijke Schreurs(University Medical Center Groningen), Ronit Shiri‐Sverdlov(Maastricht University), Rinke Stienstra(Radboud University Nijmegen), Pascal P. H. Hommelberg(University Medical Center Groningen), Alain de Bruin(Utrecht University)
Cited by 41
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
|Developmental Cell|2014|2k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2020|1.5k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k